Literature DB >> 822509

Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei.

K Hannestad, A Johannessen.   

Abstract

Antibodies to human IgG (rheumatoid factors (RF) from serum Han resembled the 'intermediate' complexes of sera from some patients with rheumatoid arthritis. These RF were isolated from heat-inactivated serum by affinity chromatography on agarose-coupled human IgG. Indirect immunofluorescence revealed that the isolated RF cross-reacted with cell nuclei from many species. Virtually all the antinuclear factor (ANF) activity of this serum was extracted by IgG-agarose. Alternative explanations of this phenomenon, such as nonspecific binding of a separate population of ANF, binding of ANF to the immunosorbent via an IgG RF-IgG ANF immune complex, or presence of nuclear antigens on the immunosorbent, were ruled out. The cross-reacting antibodies possessed both kappa and lambda light chains and predominantly gamma and some mu heavy chains, indicating that they were of polyclonal origin. The antinuclear activity was present in the F(ab')2 fragments. The interpretation of this strange cross-reaction is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822509     DOI: 10.1111/j.1365-3083.1976.tb00309.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  18 in total

Review 1.  Rheumatoid factor cross idiotypes.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Cross-reacting rheumatoid factors and lupus erythematosus (LE)-factors.

Authors:  K Hannestad; O P Rekvig; A Husebekk
Journal:  Springer Semin Immunopathol       Date:  1981

3.  Cultured human endothelial cells display an antigen that is recognized by certain human anti-chromatin autoantibodies.

Authors:  M Horneland; O P Rekvig; L Jørgensen; K Hannestad
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Method for avoiding false-positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodies.

Authors:  Y Naot; E V Barnett; J S Remington
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

5.  Physiology and pathology of rheumatoid factors.

Authors:  D A Carson; J L Pasquali; C D Tsoukas; S Fong; S F Slovin; S K Lawrance; L Slaughter; J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1981

6.  Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

Authors:  J C Mason; P J Venables; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

7.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

8.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: immunopathological implications?

Authors:  P M Johnson
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

10.  Human monoclonal rheumatoid factors: incidence of cross-reactions with tissue components and correlation with VH gene usage.

Authors:  S J Thorpe; M Børretzen; S W Bailey; I Randen; J B Natvig; K M Thompson
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.